Booth Bruce

DirectorKymera Therapeutics, Inc. (KYMR) · full profile →Form 4/A · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8.3M
Net Open-Market Flow
-$8.3M
Transactions
14
14 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Sell(S)6K$105.78$587K2.4M
Jun 29, 2026Sell(S)15K$106.63$1.6M2.4M
Jun 29, 2026Sell(S)19K$107.76$2.1M2.4M
Jun 29, 2026Sell(S)11K$108.28$1.2M2.4M
Jun 29, 2026Sell(S)8K$109.75$874K2.4M
Jun 29, 2026Sell(S)8K$110.67$855K2.4M
Jun 29, 2026Sell(S)934$111.20$104K2.4M
Jun 29, 2026Sell(S)770$105.78$81K471K
Jun 29, 2026Sell(S)2K$106.63$227K469K
Jun 29, 2026Sell(S)3K$107.76$291K467K
Jun 29, 2026Sell(S)1K$108.28$162K465K
Jun 29, 2026Sell(S)1K$109.75$121K464K
Jun 29, 2026Sell(S)1K$110.67$119K463K
Jun 29, 2026Sell(S)130$111.20$14K463K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001451612-26-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly: